Many Generic Drugs Haven’t Hit Market, Hindering Cost-Control Efforts

  • 📰 WSJ
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

México Noticias Noticias

México Últimas Noticias,México Titulares

To curb high drug costs, the U.S. has approved record numbers of generic drugs in recent years. But only a fraction have gone on sale.

Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S. approval in recent years, raising hopes that the new competition would reduce high drug costs. But many of the lower-price medicines haven’t hit the market, a Wall Street Journal review found.

The result: Many patients are forced to take high-price medicines, and a widely touted remedy for reining in drug costs has failed to live up to its promise.

 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 98. in MX

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Double-whammy of Brexit and election hits UK housing market - surveyThe number of properties put up for sale in Britain has fallen by the most in an...
Fuente: Reuters - 🏆 2. / 97 Leer más »